We present data on cancer chemotherapy-related pharmacogene variant frequencies in DPYD, UGT1A1, TPMT, NUDT15, and ABCB1 within the Chilean population, offering insights for the strategic implementation of pharmacogenetic testing. This evidence concerns the gene TPMT and cancer.